Please note most of these publications were published by our predecessor company CellPoint, LLC.

CENTENNIAL, Colo., June 3, 2010

Cell>Point announced today that it will present clinical results for its cancer imaging agent, 99mTc-EC-G, used to assess the efficacy of chemotherapy at the 2010 Society of Nuclear Medicine Annual Meeting on June 7, 2010.